Sunwin Stevia International, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2019
September 16, 2019 at 01:18 pm EDT
Share
Sunwin Stevia International, Inc. announced earnings results for the first quarter ended July 31, 2019. For the first quarter, the company announced total revenue was USD 6.890 million compared to USD 4.997 million a year ago. Operating income was USD 37,862 compared to operating loss of USD 916,802 a year ago. Net loss was USD 383,235 compared to USD 1.190 million a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.01 a year ago.
Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.